why choose us

First received: June 04, 2023

Clinical Trial: Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma

Study Type: INTERVENTIONAL


Official Title: Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma

Brief Summary: Therefore, we intend to conduct a phase II study to evaluate the efficacy of maintenance therapy with lenalidomide as the maintenance therapy for patients with PCNSL or PVRL who have achieved CR or partial response after HD-MTX-based induction therapy followed by reduced-dose WBRT.Twentypatients with PCNSL or PVRL will be recruited.The primary outcome is 2-year progression-free survival from the first date of reduced-dose WBRT.Besides, the safety and the incidence of cute and late neurotoxicity related to…

Read more